Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study.
Noa Ofek ShlomaiGilad LazarovitzBenjamin Z KoplewitzSmadar Eventov FriedmanPublished in: Children (Basel, Switzerland) (2023)
Cumulative PGE1 dose is associated with gastrointestinal adverse effects in neonates. Lower doses should be considered in neonates expecting prolonged PGE1 treatment.